Dr. Timothy Kuzel, MD, FACP

Dr. Timothy Kuzel, MD, FACP

Work:

Samuel G. Taylor III MD Professor of Oncology, Rush University Medical College

Education:

Doctor of Medicine, University of Michigan Medical School

Dr. Timothy M. Kuzel has over 32 years of experience in the fields of Medical Oncology and Hematology. He earned his BA in Biomedical Sciences from the University of Michigan and his MD from the University of Michigan Medical School. He completed both an internship and residency in Internal Medicine at the McGaw Medical Center of Northwestern University before completing a fellowship in Hematology and Oncology at Northwestern Memorial Hospital. Today, this expert is board-certified in Internal Medicine, Hematology, and Medical Oncology. Formerly, this expert served as the Director of the Walter S. and Lucienne Driskill Immunotherapy Research Program and as a Professor of Medicine and Dermatology at the Northwestern University Feinberg School of Medicine. He currently serves as the Chief of the Division of Hematology, Oncology, and Cell Therapy and as the Samuel G. Taylor III MD Professor of Oncology at Rush University Medical College. He is also the Interim Deputy Director for Clinical Affairs at Rush University Cancer Center within Rush University Medical Center.

email icon

t*********@r****.edu

phone icon

(312) ***-****

location icon

Chicago, Illinois

At a Glance

Expert Witness Activity

lock icon

Plaintiff Cases

lock icon

Defense Cases

5

Expert Challenges

lock icon

Deposition Transcripts

lock icon

Publications

265

Media & News

232

Social Media Mentions

lock icon

Expert Institute operates independently and objectively as an expert witness data provider. Expert witness profiling focuses on individuals involved in publicly disclosed litigation. Expert Institute does not employ, endorse, or suggest an affiliation with any individuals for whom data is available.

Litigation Activities

Case Name

Role

Filed Date

Richard Wyzik, et al. v. Monsanto Company, et al.

Expert Witness

2021-02-10

green checkmark

Unlock Dr. Timothy Kuzel, MD, FACP's full profile

See their litigation activity, risk and credibility history

Litigation Analytics

Retained By

Defense

Plaintiff

Other

Activity over time

0

25

50

75

100

2000

0

2002

0

2004

0

2006

0

2008

0

2010

0

Area of Law

2001-2009

2001-2009

2001-2009

2001-2009

2001-2009

2001-2009

2001-2009

2001-2019

0

25

50

75

100

Activity by state

Map of USA

Case Outcome

0

25

50

75

100

Unlock Dr. Timothy Kuzel, MD, FACP's full profile

See their litigation activity, risk and credibility history

Publications

265 records available

Title

Type

Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas

Journal Article

Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer

Journal Article

Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial

Journal Article

green checkmark

Unlock Dr. Timothy Kuzel, MD, FACP's full profile

See their litigation activity, risk and credibility history

5 stars

Using Expert Radar, we uncovered a textbook chapter written by the opposing expert that contradicted his testimony, helping us secure a $44 million verdict—the largest single verdict for a single plaintiff in Kentucky's history.

Mark Alcott, Esq.

Harlin Parker

Media & News

232 records available

Title

Description

St. George Corporation Gives $51 Million to Northwestern ...

Jan 31, 2024 ----- Northwestern Medicine . Dr . Timothy Kuzel , director for oncology at Palos Hospital in Illinois, speaks during the announcement of St. George ...

Top Doctors 2024 – Chicago Magazine

Jan 2, 2024 ----- Primary Care . Family Medicine . Guy J. Agostino ... Timothy M . Kuzel Near West Side (Rush) ... physicians and clinicians to its health and wellness ...

Northwestern St. George Cancer Institute adds services

Dec 28, 2023 ----- Timothy Kuzel as medical director of the institute. A cancer diagnosis is a traumatic event and not just for the individual, but it really ...

green checkmark

Unlock Dr. Timothy Kuzel, MD, FACP's full profile

See their litigation activity, risk and credibility history

Education

Institution

Degree Type

University of Michigan Medical School

Doctor of Medicine

University of Michigan

Bachelor of Arts

Work History

Title

Employer

Samuel G. Taylor III MD Professor of Oncology

Rush University Medical College

Interim Deputy Director for Clinical Affairs

Rush University Medical Center

Chief

Rush University Medical College

Get critical intel on Dr. Timothy Kuzel, MD, FACP

lock icon

Contradictory statements in testimony

lock icon

Misrepresentations in CVs, online profiles / bios, LinkedIn

lock icon

Biases in expert witness experience

lock icon

Financial ties with organizations they represent

Related Experts